In CRC, DBC1 promotes the formation of the LEF1-β-catenin complex in the Wnt signaling pathway by reducing SIRT1-mediated β-catenin deacetylation, thereby enhancing Wnt-β-catenin signaling and worsening prognosis in CRC patients (53, 54). Here, LEF1 is linked to colorectal carcinoma.